Why the study?
Does controlling paclitaxel particle size in drug-eluting stents improve in-stent restenosis and vascular recovery in vivo?
Does controlling paclitaxel particle size in drug-eluting stents improve in-stent restenosis and vascular recovery in vivo?
Controlling paclitaxel particle size to approximately 50 nm in drug-eluting stents optimizes drug release and improves in vivo efficacy against in-stent restenosis while preserving vascular recovery.
Answers are grounded in this paper and cite their sources.
50-nm PTX particles may optimize DES performance in ISR models; leaves open clinical translation and vascular healing effects.
Drug-eluting stents (DESs) are generally used in percutaneous coronary intervention. Paclitaxel (PTX) is widely used in DESs to suppress neointima, which causes restenosis. However, the PTX release profile is slow owing to its hydrophobic properties, resulting in negative effects on re-endothelialization in vessels. In this study, we assessed the effects of the controlled release of PTX particles of specific sizes on in-stent restenosis (ISR). PTX particle sizes were controlled by adjusting the evaporating temperature of the solvent from 25 to 80°C during ultrasonic coating, and DESs were prepared. The properties of prepared films and DESs were analyzed, and cell viability was assessed in vitro and in vivo. Poly(lactic-co-glycolic acid) (PLGA)/PTX500-loaded stents showed the most rapid release for 58 days, and smaller drug particles exhibited lower PTX release rates. In vivo, PLGA/PTX50-, PLGA/PTX250-, and PLGA/PTX500-loaded stents showed good efficacy for alleviating ISR as compared with bare metal stents and PLGA/PTX5-loaded stents. However, PLGA/PTX250- and PLGA/PTX500-loaded stents exhibited strut exposure and reduced recovery of the vascular compared with PLGA/PTX50-loaded stents. PTX drug particles of approximately 50 nm were most effective in vivo, and the control of particle size is a promising strategy for improving the performance of PTX-eluting stents.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: